vs

Side-by-side financial comparison of Dolby Laboratories, Inc. (DLB) and MARCUS CORP (MCS). Click either name above to swap in a different company.

Dolby Laboratories, Inc. is the larger business by last-quarter revenue ($346.7M vs $193.5M, roughly 1.8× MARCUS CORP). On growth, MARCUS CORP posted the faster year-over-year revenue change (2.8% vs -2.9%). Over the past eight quarters, MARCUS CORP's revenue compounded faster (18.2% CAGR vs 9.6%).

Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.

Marcus & Millichap, Inc. is an American company that provides real estate brokerage, mortgage brokerage, research, and advisory services in the U.S. and Canada in the field of commercial property. It popularized the practice of listing properties exclusively with one brokerage firm. The company has over 1,800 employees in more than 80 offices across the U.S. and Canada.

DLB vs MCS — Head-to-Head

Bigger by revenue
DLB
DLB
1.8× larger
DLB
$346.7M
$193.5M
MCS
Growing faster (revenue YoY)
MCS
MCS
+5.6% gap
MCS
2.8%
-2.9%
DLB
Faster 2-yr revenue CAGR
MCS
MCS
Annualised
MCS
18.2%
9.6%
DLB

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
DLB
DLB
MCS
MCS
Revenue
$346.7M
$193.5M
Net Profit
$53.3M
Gross Margin
87.5%
Operating Margin
17.9%
0.9%
Net Margin
15.4%
Revenue YoY
-2.9%
2.8%
Net Profit YoY
-21.4%
EPS (diluted)
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DLB
DLB
MCS
MCS
Q1 26
$346.7M
Q4 25
$346.7M
$193.5M
Q3 25
$307.0M
$210.2M
Q2 25
$315.5M
$206.0M
Q1 25
$369.6M
$148.8M
Q4 24
$357.0M
$188.3M
Q3 24
$304.8M
$232.7M
Q2 24
$288.8M
$176.0M
Net Profit
DLB
DLB
MCS
MCS
Q1 26
$53.3M
Q4 25
$53.3M
Q3 25
$49.3M
$16.2M
Q2 25
$46.1M
$7.3M
Q1 25
$91.8M
$-16.8M
Q4 24
$67.8M
$986.0K
Q3 24
$58.6M
$23.3M
Q2 24
$38.4M
$-20.2M
Gross Margin
DLB
DLB
MCS
MCS
Q1 26
87.5%
Q4 25
87.5%
Q3 25
87.1%
Q2 25
86.1%
Q1 25
90.3%
Q4 24
88.6%
Q3 24
88.8%
Q2 24
87.7%
Operating Margin
DLB
DLB
MCS
MCS
Q1 26
17.9%
Q4 25
17.9%
0.9%
Q3 25
9.7%
10.8%
Q2 25
15.1%
6.3%
Q1 25
29.2%
-13.7%
Q4 24
22.4%
-1.2%
Q3 24
15.2%
14.1%
Q2 24
12.7%
1.3%
Net Margin
DLB
DLB
MCS
MCS
Q1 26
15.4%
Q4 25
15.4%
Q3 25
16.1%
7.7%
Q2 25
14.6%
3.6%
Q1 25
24.8%
-11.3%
Q4 24
19.0%
0.5%
Q3 24
19.2%
10.0%
Q2 24
13.3%
-11.5%
EPS (diluted)
DLB
DLB
MCS
MCS
Q1 26
$0.55
Q4 25
$0.55
Q3 25
$0.50
Q2 25
$0.48
Q1 25
$0.94
Q4 24
$0.70
Q3 24
$0.59
Q2 24
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DLB
DLB
MCS
MCS
Cash + ST InvestmentsLiquidity on hand
$644.6M
$23.4M
Total DebtLower is stronger
$159.0M
Stockholders' EquityBook value
$2.6B
$457.4M
Total Assets
$3.2B
$1.0B
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DLB
DLB
MCS
MCS
Q1 26
$644.6M
Q4 25
$644.6M
$23.4M
Q3 25
$702.6M
$7.4M
Q2 25
$699.3M
$14.9M
Q1 25
$626.6M
$11.9M
Q4 24
$520.8M
$40.8M
Q3 24
$482.0M
$28.4M
Q2 24
$869.0M
$32.8M
Total Debt
DLB
DLB
MCS
MCS
Q1 26
Q4 25
$159.0M
Q3 25
$162.0M
Q2 25
$179.9M
Q1 25
$198.9M
Q4 24
$159.1M
Q3 24
$173.1M
Q2 24
$175.7M
Stockholders' Equity
DLB
DLB
MCS
MCS
Q1 26
$2.6B
Q4 25
$2.6B
$457.4M
Q3 25
$2.6B
$454.3M
Q2 25
$2.6B
$448.4M
Q1 25
$2.6B
$441.8M
Q4 24
$2.5B
$464.9M
Q3 24
$2.5B
$462.3M
Q2 24
$2.4B
$449.4M
Total Assets
DLB
DLB
MCS
MCS
Q1 26
$3.2B
Q4 25
$3.2B
$1.0B
Q3 25
$3.2B
$1.0B
Q2 25
$3.2B
$1.0B
Q1 25
$3.2B
$1.0B
Q4 24
$3.2B
$1.0B
Q3 24
$3.1B
$1.0B
Q2 24
$3.0B
$1.1B
Debt / Equity
DLB
DLB
MCS
MCS
Q1 26
Q4 25
0.35×
Q3 25
0.36×
Q2 25
0.40×
Q1 25
0.45×
Q4 24
0.34×
Q3 24
0.37×
Q2 24
0.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DLB
DLB
MCS
MCS
Operating Cash FlowLast quarter
$54.8M
$48.8M
Free Cash FlowOCF − Capex
$26.4M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
11.6%
Cash ConversionOCF / Net Profit
1.03×
TTM Free Cash FlowTrailing 4 quarters
$989.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DLB
DLB
MCS
MCS
Q1 26
$54.8M
Q4 25
$54.8M
$48.8M
Q3 25
$472.2M
$39.1M
Q2 25
$67.7M
$31.6M
Q1 25
$174.9M
$-35.3M
Q4 24
$106.8M
$52.6M
Q3 24
$327.3M
$30.5M
Q2 24
$21.3M
$36.0M
Free Cash Flow
DLB
DLB
MCS
MCS
Q1 26
Q4 25
$50.2M
$26.4M
Q3 25
$435.9M
$18.2M
Q2 25
$61.3M
$14.7M
Q1 25
$168.0M
$-58.3M
Q4 24
$100.0M
$27.1M
Q3 24
$297.2M
$12.0M
Q2 24
$13.7M
$16.1M
FCF Margin
DLB
DLB
MCS
MCS
Q1 26
Q4 25
14.5%
13.6%
Q3 25
142.0%
8.7%
Q2 25
19.4%
7.1%
Q1 25
45.5%
-39.2%
Q4 24
28.0%
14.4%
Q3 24
97.5%
5.2%
Q2 24
4.7%
9.2%
Capex Intensity
DLB
DLB
MCS
MCS
Q1 26
Q4 25
1.3%
11.6%
Q3 25
11.8%
9.9%
Q2 25
2.0%
8.2%
Q1 25
1.9%
15.5%
Q4 24
1.9%
13.5%
Q3 24
9.8%
7.9%
Q2 24
2.6%
11.3%
Cash Conversion
DLB
DLB
MCS
MCS
Q1 26
1.03×
Q4 25
1.03×
Q3 25
9.57×
2.41×
Q2 25
1.47×
4.32×
Q1 25
1.91×
Q4 24
1.57×
53.31×
Q3 24
5.59×
1.31×
Q2 24
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DLB
DLB

Licensing$319.8M92%
Products and services$26.9M8%

MCS
MCS

Theatres$123.1M64%
Concessions$51.0M26%
Food And Beverage$21.2M11%

Related Comparisons